Scorpius Holdings

SCPX · NYSE American

$0.0001+$0.0001 (+0.00%)TodayMarket closed · Oct 20, 9:30 AM ET

No price history for this range.

About SCPX

Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in San Antonio, Texas and currently employs 89 full-time employees. The company went IPO on 2013-07-24. The firm was previously a contract development and manufacturing organization.

Employees: 89
Headquarters: San Antonio, Texas
Listed: Jul 24, 2013
Sector: Health Care
Industry: Biotechnology
Website: nighthawkbio.com

Leadership

Scorpius Holdings executives
Name	Title	Since	Age
Jeffrey Wolf	—	2008	62
William Ostrander	—	—	56
Kit Foo Chye	—	—	57
John Monahan	—	—	78
Edward Smith	—	—	49

Similar companies

Companies in the same industry as Scorpius Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.